ResMed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various …
Medical - Instruments & Supplies
US, San Diego [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q2 | Q3 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | 15.54 | 66.99 | 57.98 | |
| Graham Fair Price | 22.07 | 38.07 | 31.19 | |
| PEG | -91.78 | 0.53 | -6.45 | |
| Price/Book | 6.41 | 6.01 | 5.65 | |
| Price/Cash Flow | -27.97 | 73.42 | 101.94 | |
| Prices/Earnings | -23.62 | 23.15 | 30.30 | |
| Price/Sales | 6.79 | 23.24 | 21.77 | |
| Price/FCF | -27.97 | 73.42 | 101.94 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q2 | Q3 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | 2.35 | 0.57 | 0.56 | |
| Operating Margin | 32.28 | 0.31 | 0.24 | |
| ROA | 45.83 | 0.04 | 0.03 | |
| ROE | 0.05 | 0.06 | 39.31 | |
| ROIC | 0.04 | 0.05 | 40.51 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q2 | Q3 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | -0.16 | -0.07 | -130.82 | |
| Dividends QOQ | < 0.005 | < 0.005 | 91.91 | |
| EBIT QOQ | -0.05 | 0.36 | 651.77 | |
| EPS QOQ | -0.05 | 0.44 | 829.38 | |
| FCF QOQ | 0.01 | 0.53 | 4420.29 | |
| Revenue QOQ | 0.21 | 0.03 | -85.83 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Positive
Fundamentals
Leverage & Liquidity
| Metric | Q2 | Q3 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 162.81 | 144.84 | -11.04 | |
| Days Sales Outstanding (DSO) | 56.48 | 61.44 | 8.79 | |
| Inventory Turnover | 0.55 | 0.62 | 12.41 | |
| Debt/Capitalization | 0.24 | 0.18 | -23.11 | |
| Quick Ratio | 1.24 | 1.39 | 12.30 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q2 | Q3 | Δ in % | |
|---|---|---|---|---|
| Book Value | 30.46 | 31.50 | 3.43 | |
| Cash | 1.48 | 1.77 | 19.23 | |
| Capex | -0.17 | -0.16 | 5.79 | |
| Free Cash Flow | 1.69 | 2.58 | 52.80 | |
| Revenue | 7.90 | 8.14 | 3.06 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Best
Fundamentals
Financial Health
06 - Financial Health ·
Bad